A study for a 83 year old man who takes Escitalopram, Eliquis, Enalapril Maleate (an AI-powered real world drug study)
Summary:
518 males aged 83 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 83 year old male patient who has Anxiety, Cad. The study is created by eHealthMe based on reports from sources including the FDA.
518 males aged 83 (±5) who take Escitalopram, Eliquis, Enalapril Maleate and have adverse effects are studied.
Number of reports submitted per year:

Information of the patient in this study:
- Age: 83
- Gender: male
What are the drugs?
- Escitalopram has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 78,081 Escitalopram users. Check the latest studies of Escitalopram.
- Eliquis has active ingredients of apixaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 191,861 Eliquis users. Check the latest studies of Eliquis.
- Enalapril maleate has active ingredients of enalapril maleate. It is often used in high blood pressure. eHealthMe is studying from 33,597 Enalapril maleate users. Check the latest studies of Enalapril maleate.
What are the conditions?
- Anxiety is found to be associated with 4,326 drugs and 5,476 conditions by eHealthMe. Check the latest studies of Anxiety.
- Cad is found to be associated with 1,436 drugs and 2,159 conditions by eHealthMe. Check the latest studies of Cad.
Common drug interactions *:
- Death : 54 people, 10.42%
- Pneumonia : 32 people, 6.18%
- Fall : 30 people, 5.79%
- Weakness : 28 people, 5.41%
- Fatigue (feeling of tiredness): 25 people, 4.83%
- Dizziness : 25 people, 4.83%
- Hypotension (abnormally low blood pressure): 25 people, 4.83%
- Nausea (feeling of having an urge to vomit): 22 people, 4.25%
- Cardiac Failure : 21 people, 4.05%
- Dyspnea (difficult or laboured breathing): 20 people, 3.86%
- Diarrhea : 20 people, 3.86%
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 18 people, 3.47%
- Drowsiness : 18 people, 3.47%
- Dehydration (dryness resulting from the removal of water): 18 people, 3.47%
- Cardiac Failure Congestive : 17 people, 3.28%
- Weight Decreased : 16 people, 3.09%
- Urinary Tract Infection : 16 people, 3.09%
- Nausea And Vomiting : 16 people, 3.09%
- Renal Impairment (severely reduced kidney function): 16 people, 3.09%
- Anaemia (lack of blood): 15 people, 2.90%
Common co-existing conditions *:
You may use this to check any potential undetected conditions.
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 89 people, 17.18%
- Multiple Myeloma (cancer of the plasma cells): 42 people, 8.11%
- Cardiac Failure : 32 people, 6.18%
- High Blood Cholesterol : 24 people, 4.63%
- Prostate Cancer : 19 people, 3.67%
- Parkinson's Disease : 19 people, 3.67%
- Dyslipidaemia (abnormal amount of lipids): 18 people, 3.47%
- Hallucinations (sensations that appear real but are created by your mind): 17 people, 3.28%
- Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 17 people, 3.28%
- Diabetes : 16 people, 3.09%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 14 people, 2.70%
- Hyperlipidaemia (presence of excess lipids in the blood): 13 people, 2.51%
- Insomnia (sleeplessness): 12 people, 2.32%
- Type 2 Diabetes : 11 people, 2.12%
- Delusion (a false belief or opinion): 11 people, 2.12%
- Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 11 people, 2.12%
- Neuralgia (pain in one or more nerves): 11 people, 2.12%
- Cardiac Disorder : 9 people, 1.74%
- Pain : 9 people, 1.74%
- Arrhythmias (irregular heartbeat): 9 people, 1.74%
Common co-used drugs *:
You may use this to check any potential interacting drugs.
- Pantoprazole (58 people, 11.20%)
- Amlodipine (53 people, 10.23%)
- Furosemide (45 people, 8.69%)
- Lasix (43 people, 8.30%)
- Tamsulosin (41 people, 7.92%)
- Metformin (41 people, 7.92%)
- Vitamin B12 (32 people, 6.18%)
- Vitamin D3 (30 people, 5.79%)
- Aspirin (30 people, 5.79%)
- Spironolactone (29 people, 5.60%)
- Revlimid (29 people, 5.60%)
- Bactrim (26 people, 5.02%)
- Entresto (25 people, 4.83%)
- Omeprazole (25 people, 4.83%)
- Lipitor (23 people, 4.44%)
- Melatonin (22 people, 4.25%)
- Prednisone (22 people, 4.25%)
- Nuplazid (22 people, 4.25%)
- Dexamethasone (22 people, 4.25%)
- Paracetamol (22 people, 4.25%)
Drug effectiveness *:
Escitalopram:
- not at all: 0 %
- somewhat: 100 %
- moderate: 0 %
- high: 0 %
- very high: 0 %
Eliquis:
- not at all: 0 %
- somewhat: 0 %
- moderate: 0 %
- high: 100 %
- very high: 0 %
Enalapril Maleate:
n/a
* Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Drug side effects in long term, by gender and age:
- Eliquis: 191,861 reports
- Enalapril maleate: 33,597 reports
- Escitalopram: 78,081 reports
Drug interactions:
- Escitalopram and Eliquis drug interaction (47 reports)
- Escitalopram and Enalapril maleate drug interaction (182 reports)
- Eliquis and Enalapril maleate drug interaction (261 reports)
How the phase IV clinical study uses the data?
The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lamictal and Obsessive-Compulsive Disorder for Women aged 20-29 - 10 seconds ago
- Lamictal and Obsessive-Compulsive Neurosis for Women aged 20-29 - 10 seconds ago
- Lamictal and Ocd for Women aged 20-29 - 11 seconds ago
- Lamictal and Itchiness for Women aged 30-39 - 18 seconds ago
- Lamictal and Pruritus for Women aged 30-39 - 18 seconds ago
- Lamictal and Itching for Women aged 30-39 - 18 seconds ago
- Photophobia in Wellbutrin, how severe and when it was recovered? - 22 seconds ago
- Drug interactions of Allopurinol and Melphalan Hydrochloride - 31 seconds ago
- Could Sucralfate cause Infusion Site Pruritus? - 36 seconds ago
- Effexor and Flaxseed drug interactions for women aged 60+ - 57 seconds ago